How to Prepare a Dental Practice for Sale: A 24-Month Operator's Timeline

The most expensive mistake a dental practice owner makes when selling is starting too late.

By the time most dentists decide to sell — whether to a DSO, a private equity-backed group, or an individual buyer — they have six to twelve months of runway before they want to close. That is not enough time to address the operational, financial, and compliance gaps that sophisticated buyers will find in due diligence. It is not enough time to meaningfully improve EBITDA. And it is not enough time to build the documentation that supports the valuation you deserve.

The practices that achieve the highest valuations — and close with the fewest surprises — typically begin preparation 18 to 24 months before going to market. Not because the process takes that long. But because meaningful EBITDA improvement, compliance remediation, and operational optimization all require time to show up in the financial statements that buyers evaluate.

This guide covers the complete 24-month preparation timeline — what to do, when to do it, and why each step matters for your final transaction value.

Why Preparation Timeline Matters More Than Most Sellers Realize

DSO buyers and private equity sponsors evaluate trailing twelve-month and trailing twenty-four-month financial performance. A practice that improved its EBITDA margin from 28% to 36% in month 13 before closing — just outside the trailing twelve-month window — receives no credit for that improvement in the buyer's valuation model.

Operational improvements need time to season in the financial statements. Compliance gaps identified and remediated twelve months before the letter of intent are a resolved historical issue. The same gaps identified during due diligence are a current liability that sophisticated buyers will use to reduce the purchase price, add indemnification provisions, or introduce holdback structures that put your proceeds at risk.

Unrepresented sellers negotiating directly with DSOs and PE-backed buyers routinely leave 20–40% of deal value on the table. Much of that gap is not negotiating skill — it is preparation. A seller who has spent 24 months optimizing their practice for maximum valuation negotiates from a fundamentally different position than one who decided to sell six months ago.

Months 24–18: Foundation and Assessment

Get an Honest Baseline

The starting point of any serious sale preparation is understanding exactly where the practice stands — financially, operationally, and from a compliance perspective. Not where you think it stands. Where it actually stands based on the data a buyer will see.

Commission a practice valuation from a dental-specific advisor who understands current market multiples and buyer evaluation criteria. Not a general business valuation — a dental-specific one that reflects how DSOs and PE-backed buyers actually calculate and apply EBITDA multiples in today's transaction environment.

The valuation will tell you two things: what the practice is worth today, and — more importantly — what the specific gaps are between current performance and the valuation you could achieve with preparation.

Calculate your recast EBITDA immediately. PE buyers will recast your EBITDA using their methodology — adding back above-market owner compensation, personal expenses run through the practice, and one-time costs. Knowing your recast EBITDA before a buyer calculates it for you is one of the most important financial steps in preparation. A practice with $400,000 in reported EBITDA but $700,000 in recast EBITDA — once above-market owner compensation and personal expenses are added back — is worth dramatically more at a 7x multiple. That difference is yours to capture only if you understand and document it before negotiations begin.

Engage the Right Advisors Early

The quality of your advisory team is the single most important factor in transaction outcome outside of the practice itself. Three specific advisors are non-negotiable for a DSO or PE-backed transaction.

A dental-specific M&A advisor or broker. Not a general business broker. Not your accountant's colleague who has done a few practice sales. A dental-specific advisor with active relationships with DSO and PE buyers, knowledge of current market multiples by geography and practice type, and recent transaction experience. Unrepresented sellers leave money on the table because buyers know current market multiples and sellers don't. Your advisor's job is to close that information gap.

A dental CPA with DSO transaction experience. Your current accountant may be excellent at tax preparation and financial statement compilation. They may not understand how PE buyers recast EBITDA, which add-backs are defensible versus which will be challenged, or how transaction structure affects your after-tax proceeds. These distinctions are worth tens or hundreds of thousands of dollars. Engage a CPA who has guided dentists through DSO transactions.

A healthcare attorney experienced in DSO transactions. Not your general business attorney. DSO transactions involve specific legal structures — professional corporation requirements, state DSO ownership rules, associate employment agreements, non-compete provisions, rollover equity documents, and representations and warranties — that general business counsel is not equipped to navigate. Engage a healthcare attorney with specific DSO transaction experience before the letter of intent stage.

Conduct a Compliance Audit

PE buyers run a HIPAA compliance audit as part of due diligence. Gaps discovered during due diligence create indemnification exposure that buyers will price into the deal — as purchase price reductions, escrow holdbacks, or post-close indemnification provisions. The same gaps identified and remediated before going to market are a resolved historical issue that creates no leverage for the buyer.

Engage a healthcare compliance attorney or consultant to audit the following:

• HIPAA compliance — policies, training records, business associate agreements with vendors, and breach history. PE buyers specifically flag outdated BAAs, undocumented training, and any historical breach incidents.
• OSHA compliance — safety manual currency, bloodborne pathogen training documentation, hazard communication logs, and exposure control plans.
• Associate classification — whether clinical staff are correctly classified as employees versus independent contractors. In many states, 1099 associate classification is a compliance violation that creates payroll tax liability and regulatory exposure. Remediating this 18+ months before sale gives the corrected structure time to establish before buyers evaluate it.
• Billing compliance — consistent billing practices across all providers, documentation quality supporting procedures billed, and compliance with payer contract requirements.
• Corporate structure — whether the practice's corporate structure complies with your state's DSO ownership rules. This is particularly important if you have or plan to have multiple locations.

Months 18–12: Operational Optimization

Revenue Cycle Improvement

The revenue cycle is where the highest-ROI pre-sale improvements are available — and where the improvements take the most time to show up in the financials. Starting 18 months before a planned close gives the improvements 12+ months to season in the trailing financial statements buyers evaluate.

Collections rate. Net collection rate should be above 98%. Every percentage point below 98% represents revenue the practice was entitled to collect but didn't. A practice collecting $1.5M annually at a 94% net collection rate is losing $60,000 annually to preventable collections failures. Improving to 98% adds $60,000 to EBITDA — at a 7x multiple, that's $420,000 in additional transaction value.

Insurance AR aging. Insurance accounts receivable over 90 days should be below 20% of total insurance AR. High AR aging signals collection process failures to buyers and depresses the quality-of-earnings assessment applied to revenue.

Denial rate. Denial rate above 8% signals systematic RCM process failures. Implement a structured denial management process targeting the top denial reason codes by payer and track resolution rates monthly.

Fee schedule benchmarking. Compare contracted rates against FairHealth 70th percentile benchmarks for your top 20 to 30 procedure codes by payer. Rates that lag market benchmarks represent a negotiation opportunity that, once captured, compounds in every subsequent year's financial statements.

Treatment Plan Conversion

Treatment plan conversion rate is one of the most reliable leading indicators of practice health — and one of the most actionable pre-sale improvements available. The industry benchmark is 55–65% of presented treatment accepted. Most practices convert 35–50%.

A 10-point improvement in treatment plan conversion rate on $2M in annually presented treatment generates $200,000 in additional collections — with no additional marketing spend, no additional patients, and no additional clinical capacity. At a 7x EBITDA multiple and assuming a 35% EBITDA margin on that revenue, a 10-point conversion improvement adds approximately $490,000 in transaction value.

The root cause of low conversion is almost always in the patient communication and financial presentation process — not in clinical quality or patient relationships. Structured training for frontline teams on communicating recommended care and presenting financial arrangements consistently improves conversion rates within 60 to 90 days of implementation.

Supply Chain Optimization

Supply costs averaging 18–20% of collections versus a best-practice benchmark of 11–13% represent pure EBITDA drag that is visible to every buyer who reviews the practice's financial statements. Reducing supply costs from 18% to 13% on $1.5M in collections generates $75,000 in additional annual EBITDA — worth $525,000 in transaction value at a 7x multiple.

The levers are straightforward: vendor consolidation, formulary compliance, GPO participation, and ordering discipline. None of them require capital investment — only process discipline and vendor negotiation. Beginning this 18 months before closing gives the improvement 12+ months to compound in the financial statements.

Provider Productivity and Scheduling

Production per provider per day should be benchmarked against the $2,500–$4,000 range for general dentists. Schedule utilization should be at 85–92%. Hygiene production should be above 30% of total practice production.

Buyers specifically evaluate hygiene production as a percentage of total because it is the most stable and predictable revenue stream in dental — driven by recall and existing patient relationships rather than new patient acquisition or case acceptance. Practices with hygiene production below 20% of total are flagged as having weak patient retention infrastructure.

Reduce Single-Provider Concentration

The most common valuation discount factor in dental practice transactions is single-provider concentration — where the selling dentist is responsible for 70–80%+ of practice production. Buyers price this as a risk that production will decline post-transition and structure earnouts accordingly.

Adding an associate producer 12 to 18 months before going to market reduces this concentration, demonstrates that production is not dependent on the selling dentist, and shows buyers that the practice can sustain production through a transition. An associate who contributes 20–30% of production — and who has demonstrated that contribution over at least one trailing twelve-month period — meaningfully improves the quality-of-earnings assessment.

Months 12–6: Documentation and Deal Readiness

Organize Financial Documentation

Buyers will request three years of the following financial documentation. Having it organized, reconciled, and ready to deliver accelerates due diligence, signals professionalism, and prevents the delays that erode transaction momentum.

• Three years of tax returns — both business and personal. PE buyers will review personal returns to identify owner-specific expenses run through the practice that should be added back in the EBITDA recast.
• Three years of CPA-prepared profit and loss statements — monthly detail preferred, not just annual summaries.
• Current year-to-date P&L and balance sheet — updated monthly through the transaction process.
• Accounts receivable aging report — segmented by payer versus guarantor, with a clear breakdown of AR over 30, 60, 90, and 120+ days.
• Fee schedule documentation — current contracted rates by payer, organized by CPT/CDT code.

Prepare the Operations Documentation Package

Buyers evaluate operational maturity as a proxy for transition risk. A practice with documented processes, clear staff roles, and organized operational records signals lower transition risk than one that runs on founder knowledge and informal procedures.

Prepare or update the following:

• Staff documentation — org chart with tenure, compensation, and employment status for every employee. Employment agreements, non-compete provisions, and offer letters for all staff. Benefits documentation. EEOC compliance confirmation.
• Facility documentation — current lease with remaining term, renewal options, and assignment clause clearly identified. Equipment inventory with age, condition, and maintenance records. Any outstanding capex needs identified and estimated.
• Technology documentation — practice management software with license transferability confirmed. Imaging system documentation. Online review profile printouts showing current ratings across Google, Yelp, and Healthgrades.
• Insurance contracts — all payor participation agreements with confirmation that they are assignable. Any exclusivity provisions or non-compete obligations with payers or referral sources.

Address the Lease

PE buyers typically require 7–10 years of remaining lease term or renewal options at the time of acquisition. A lease with two years remaining and no renewal option is a material transaction obstacle that takes months to resolve — and cannot be resolved after the letter of intent is signed without significant delay and leverage loss.

Review your lease immediately. If remaining term plus options is below seven years, initiate renewal negotiations with your landlord now — not after you receive an LOI. A favorable lease renewal completed before going to market is a transaction facilitator. A lease renewal required by the buyer after LOI is a negotiating pressure point.

Normalize Owner Compensation

Owner compensation above market rate — typically above $250,000–$350,000 for a full-time producer in most markets — will be added back in the EBITDA recast. However, the add-back only works if it is defensible.

Document your compensation relative to market rates for your geography, specialty, and production volume. If your compensation significantly exceeds market — for example, $600,000 when market is $300,000 — the full $300,000 difference is a legitimate add-back that increases your recast EBITDA and therefore your transaction value. Buyers will calculate this regardless. Your job is to calculate it first and present it clearly.

Months 6–0: Transaction Readiness

Understand Deal Structure Before Negotiations Begin

DSO and PE-backed transactions have specific structural components that significantly affect after-tax proceeds. Understanding them before negotiations begin — not during — is essential to achieving your financial goals.

Rollover equity. Most PE-backed DSOs require the selling dentist to roll 10–30% of transaction proceeds into equity in the acquiring platform. This equity participates in the platform's future growth and eventual exit — potentially generating significant additional proceeds if the platform performs well. It also carries the risk of being worth less than the cash alternative if the platform underperforms. Model both scenarios with your financial advisor before negotiating rollover equity terms.

Earnout structure. Earnouts — additional compensation tied to post-close production targets — are commonly used to bridge valuation disagreements and manage single-provider concentration risk. Understand the production targets, measurement periods, and payment mechanisms before signing an LOI. Earnout terms accepted at the LOI stage are extremely difficult to renegotiate during due diligence.

Asset sale versus stock sale. Most dental practice acquisitions are structured as asset sales, which are generally more favorable for buyers and less favorable for sellers from a tax perspective. Stock or equity sales are sometimes negotiable depending on the transaction structure. The tax implications of each structure are significant — model both with your CPA before accepting a deal structure.

Post-close employment term. Most DSO transactions require the selling dentist to remain as an employed or contracted provider for a defined period — typically two to five years. Your post-close compensation, clinical autonomy expectations, and schedule should be explicitly negotiated before signing, not assumed based on verbal representations.

Clarify Your Non-Negotiables

Before receiving letters of intent, define your minimum acceptable terms across the key deal variables: total transaction value, cash at close percentage, rollover equity amount and terms, earnout structure, post-close employment compensation and term, clinical autonomy expectations, and non-compete scope and duration.

Buyers who know your bottom line will negotiate to it. Buyers who don't know your bottom line will find it through the negotiation process — usually at a cost to you. Your M&A advisor should negotiate with multiple buyers simultaneously to generate competitive tension that prevents any single buyer from anchoring the process at their preferred terms.

Evaluate Multiple Buyers

The single most effective way to maximize transaction value is to run a competitive process with multiple qualified buyers. Your M&A advisor should approach five to ten DSOs and PE-backed buyers simultaneously, create a structured process with defined milestones, and use competitive tension to improve terms across all variables — not just purchase price.

A practice that receives one offer negotiates against a buyer with perfect information about the alternative. A practice that receives four offers negotiates with genuine competitive tension that consistently produces better outcomes on price, rollover equity terms, earnout structure, and post-close employment provisions.

The 24-Month Preparation Checklist

Months 24–18:

• Practice valuation completed and recast EBITDA calculated
• Dental M&A advisor engaged
• Dental CPA with transaction experience engaged
• Healthcare attorney with DSO experience engaged
• Compliance audit completed — HIPAA, OSHA, billing, associate classification
• Lease term assessed and renewal initiated if needed

Months 18–12:

• Collections rate improvement underway — target 98%+
• AR aging improvement underway — insurance AR over 90 days below 20%
• Fee schedule benchmarked and negotiation initiated
• Treatment plan conversion training implemented
• Supply chain optimization underway — target 11–13% of collections
• Associate producer hired or contracted if single-provider concentration is high

Months 12–6:

• Three years of tax returns and financial statements organized and reconciled
• Staff documentation complete — org chart, employment agreements, compensation
• Equipment inventory and maintenance records organized
• Technology documentation complete — practice management, imaging, online reviews
• Payor contracts reviewed for assignability
• Owner compensation normalized and documented relative to market

Months 6–0:

• Deal structure modeled — asset sale versus stock sale, rollover equity scenarios
• Minimum acceptable terms defined across all key variables
• Competitive buyer process initiated with M&A advisor
• LOI received, reviewed, and negotiated with legal counsel
• Due diligence package delivered to buyer
• Transaction closed

Working With Viturtal Consulting on Pre-Sale Preparation

Viturtal Consulting's pre-sale preparation engagements are designed for dental practice owners who want to maximize enterprise value before going to market — not just receive a number from a broker.

Our approach begins with a quantified practice assessment that identifies the specific dollar gap between current EBITDA and achievable EBITDA with targeted operational improvement. Every recommendation is expressed in transaction value terms — not as a general operational improvement but as a specific dollar impact on what a buyer will pay.

Across published engagements, Viturtal Consulting has identified $13.2M in annual operational opportunity at a 30-location DSO and $263M at a national platform. The same frameworks apply at the single-location practice level — the dollar amounts are different, but the disciplines that drive valuation are identical.

For the financial foundation of pre-sale preparation, read our complete dental practice valuation guide — covering EBITDA multiples, buyer type differences, and the EBITDA recast methodology.

For the due diligence process from the buyer's perspective — understanding what DSOs and PE sponsors are looking for when they evaluate your practice — read our dental practice buy-side pre-sale checklist.

Contact Dr. Hendrik Lai at hendrik@viturtal.com or visit viturtal.com to schedule a consultation.